Fox Chase Cancer Center Welcomes Dr. Daniel Stapor

Daniel Stapor
Daniel Stapor, MD, an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center

PHILADELPHIA (October 29, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Daniel Stapor, MD, as an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies. He will see patients at Fox Chase, Temple Health – Jeanes Campus, Temple Health – Chestnut Hill Hospital Campus, and Temple University Hospital – Main Campus.

Stapor joins Fox Chase after completing its Hematology/Oncology Fellowship Training Program, where he was chief fellow. He brings to his new role a strong background in clinical research, cancer immunology, and survivorship care, with a focus on lymphomas and adolescent and young adult oncology.

Stapor earned his medical degree from the Lewis Katz School of Medicine at Temple University and completed his internal medicine residency at the University of Pittsburgh Medical Center. He graduated with a bachelor’s degree in biology from Duke University, where he also minored in chemistry.

As a Fox Chase fellow, Stapor led and collaborated on numerous research initiatives, including retrospective and prospective clinical trials in hematologic malignancies and stem cell transplantation. He has presented nationally on topics such as early CAR-T therapy use, measurable residual disease-guided treatment in lymphoma, and long-term outcomes in young adult patients post-transplant.

His research has been published in Genome Medicine, Blood, and The American Journal of Clinical Pathology. In 2024, he received a Young Investigator Award from proceeds raised by In Vino Vita, Fox Chase’s signature fundraising event, to further his research on the effect of chemotherapy on the immune system for patients with non-Hodgkin lymphoma.

A member of the Alpha Omega Alpha Honor Medical Society, Stapor has earned multiple accolades, including the Western Pennsylvania ACP Resident Professionalism Award and the Thomas M. Durant Prize in Internal Medicine. His work bridges laboratory investigation and clinical application, with an emphasis on improving survivorship and quality of life for cancer patients.

Stapor began his tenure at Fox Chase on September 1.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427